|
||||||||||||||||||||
|
||||||||||||||
|
Do you think the 24% drop on December 12th because Biogen could not find a buyer was overdone? Since then, the stock has rallied 3 points. What do you think is fair value? Biogen executives accelerated sale of their shares before the big drop. |
The Shelf
|